These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36935859)

  • 1. Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR) - A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group.
    Chiloiro G; Romano A; Mariani S; Macchia G; Giannarelli D; Caravatta L; Franco P; Boldrini L; Arcelli A; Bacigalupo A; Belgioia L; Fontana A; Meldolesi E; Montesi G; Niespolo RM; Palazzari E; Piva C; Valentini V; Gambacorta MA
    Clin Transl Radiat Oncol; 2023 Mar; 39():100579. PubMed ID: 36935859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.
    Guan B; Huang X; Xia H; Guan G; Xu B
    Front Oncol; 2022; 12():941786. PubMed ID: 36263216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.
    Duque-Santana V; López-Campos F; Martin-Martin M; Valero M; Zafra-Martín J; Couñago F; Sancho S
    Oncology; 2023; 101(6):349-357. PubMed ID: 36273439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.
    Dudani S; Marginean H; Tang PA; Monzon JG; Raissouni S; Asmis TR; Goodwin RA; Gotfrit J; Cheung WY; Vickers MM
    BMC Cancer; 2019 Jul; 19(1):664. PubMed ID: 31277604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
    Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer.
    Wang Y; Chen L; Zhang B; Song W; Zhou G; Xie L; Yu D
    Front Oncol; 2021; 11():639909. PubMed ID: 33816284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Eraslan E; Adas YG; Yildiz F; Gulesen AI; Karacin C; Arslan UY
    J Coll Physicians Surg Pak; 2021 Apr; 31(4):399-404. PubMed ID: 33866724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Fibrinogen-Albumin Ratio Index (FARI) is a Reliable Prognosis and Chemoradiotherapy Sensitivity Predictor in Locally Advanced Rectal Cancer Patients Undergoing Radical Surgery Following Neoadjuvant Chemoradiotherapy.
    Lu S; Liu Z; Zhou X; Wang B; Li F; Ma Y; Wang W; Ma J; Wang Y; Wang H; Fu W
    Cancer Manag Res; 2020; 12():8555-8568. PubMed ID: 32982448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy.
    Ergen ŞA; Barlas C; Yıldırım C; Öksüz DÇ
    J Gastrointest Cancer; 2022 Mar; 53(1):151-160. PubMed ID: 33392960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive significance of cancer related-inflammatory markers in locally advanced rectal cancer.
    Timudom K; Akaraviputh T; Chinswangwatanakul V; Pongpaibul A; Korpraphong P; Petsuksiri J; Ithimakin S; Trakarnsanga A
    World J Gastrointest Surg; 2020 Sep; 12(9):390-396. PubMed ID: 33024513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
    Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
    Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
    Liu M; Feng Y; Zhang Y; Liu H
    Biomed Res Int; 2022; 2022():3839670. PubMed ID: 36212713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can pretreatment platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios predict long-term oncologic outcomes after preoperative chemoradiation followed by surgery for locally advanced rectal cancer?
    An SH; Kim IY
    Ann Coloproctol; 2022 Jun; 38(3):253-261. PubMed ID: 35249276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-Lymphocyte Ratio in Rectal Cancer-Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
    Braun LH; Baumann D; Zwirner K; Eipper E; Hauth F; Peter A; Zips D; Gani C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
    Wang P; Wang Z; Liu Y; Xie J; Ren Y
    Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
    Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
    Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma.
    Zhao K; Wang C; Shi F; Li M; Yu J
    Transl Cancer Res; 2020 Jun; 9(6):3842-3853. PubMed ID: 35117751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Ding Y; Liu Z; Li J; Niu W; Li C; Yu B
    BMC Surg; 2024 Mar; 24(1):89. PubMed ID: 38481180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.